SEC Form 4 · accession 0001179110-18-006952
Strongbridge Biopharma plc · SBBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marten Steen
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 8:41 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001634432
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $7.75 | May 15, 2018 | A | 40,000 | A | May 15, 2019 | May 15, 2028 | Common Stock | 40,000 | 40,000 | I |
Explanation of responses
- F1Based on his affiliation with HealthCap VI, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.